Insitro picks up Series B

South San Francisco-based Insitro, a machine-learning driven drug discovery and development company, has raised US$143 million in Series B financing.

South San Francisco-based Insitro, a machine-learning driven drug discovery and development company, has raised US$143 million in Series B financing. Andreessen Horowitz led the round with participation from other investors that included Canada Pension Plan Investment Board, T. Rowe Price Associates, BlackRock, Casdin Capital, HOF Capital, ARCH Venture Partners, Foresite Capital, GV, Third Rock Ventures, Two Sigma Ventures and Alexandria Venture Investments.

Source: Press Release